Sandra Zwiehoff

Sandra Zwiehoff

Auto-generated profile, based on publicly available information

Sandra Zwiehoff

University of Duisburg-Essen

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 December 2021 in Small
Verified
Journal Article
Open access
PDF file
SZSandra Zwiehoff
Sandra Zwiehoff
JJJacob Johny
Jacob Johny
CBCarina Behrends
Carina Behrends
ALAlina Landmann
Alina Landmann
FMFlorian Mentzel
Florian Mentzel
SBStephan Barcikowski
Stephan Barcikowski
Proton‐based radiotherapy is a modern technique for the treatment of solid tumors with significantly reduced side effects to adjacent tissues. Biocompatible nanoparticles (NPs) with high atomic numbers are known to serve as sensitizers and to enhance treatment efficacy, which is commonly believed to be attributed to the generation of reactive oxygen species (ROS). However, little systematic knowledge is available on how either physical effects due to secondary electron generation or the particle surface chemistry affect ROS production. Thereto, ligand‐free colloidal platinum (Pt) and gold (Au) NPs with well‐controlled particle size distributions and defined total surface area are proton‐irradiated. A fluorescence‐based assay is developed to monitor the formation of ROS using terephthalic acid as a cross‐effect‐free dye. The findings indicate that proton irradiation (PI)‐induced ROS formation sensitized by noble metal NPs is driven by the total available particle surface area rather than particle size or mass. Furthermore, a distinctive material effect with Pt being more active than Au is observed which clearly indicates that the chemical reactivity of the NP surface is a main contributor to ROS generation upon PI. These results pave the way towards an in‐depth understanding of the NP‐induced sensitizing effects upon PI and hence a well‐controlled enhanced therapy.

29 July 2022 in Physics in Medicine & Biology
Verified
Journal Article
Open access
PDF file
CBC Behrends
C Behrends
CBC M Bäcker
C M Bäcker
ISIsabelle Schilling
Isabelle Schilling
SZS Zwiehoff
S Zwiehoff
JWJens Weingarten
Jens Weingarten
BTB Timmermann
B Timmermann
Objective. Due to the radiosensitizing effect of biocompatible noble metal nanoparticles (NPs), their administration is considered to potentially increase tumor control in radiotherapy. The underlying physical, chemical and biological mechanisms of the NPs’ radiosensitivity especially when interacting with proton radiation is not conclusive. In the following work, the energy deposition of protons in matter containing platinum nanoparticles (PtNPs) is experimentally investigated. Approach. Surfactant-free monomodal PtNPs with a mean diameter of (40 ± 10) nm and a concentration of 300 μg ml −1 , demonstrably leading to a substantial production of reactive oxygen species (ROS), were homogeneously dispersed into cubic gelatin samples serving as tissue-like phantoms. Gelatin samples without PtNPs were used as control. The samples’ dimensions and contrast of the PtNPs were verified in a clinical computed tomography scanner. Fields from a clinical proton machine were used for depth dose and stopping power measurements downstream of both samples types. These experiments were performed with a variety of detectors at a pencil beam scanning beam line as well as a passive beam line with proton energies from about 56–200 MeV. Main results. The samples’ water equivalent ratios in terms of proton stopping as well as the mean proton energy deposition downstream of the samples with ROS-producing PtNPs compared to the samples without PtNPs showed no differences within the experimental uncertainties of about 2%. Significance. This study serves as experimental proof that the radiosensitizing effect of biocompatible PtNPs is not due to a macroscopically increased proton energy deposition, but is more likely caused by a catalytic effect of the PtNPs. Thus, these experiments provide a contribution to the highly discussed radiobiological question of the proton therapy efficiency with noble metal NPs and facilitate initial evidence that the dose calculation in treatment planning is straightforward and not affected by the presence of sensitizing PtNPs.